Department of Cardiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki, 305-8575, Japan.
Department of Cardiology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki, 305-8575, Japan; Division of Regenerative Medicine, Transborder Medical Research Center, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba City, Ibaraki, 305-8575, Japan.
Biochem Biophys Res Commun. 2021 Jun 30;560:87-92. doi: 10.1016/j.bbrc.2021.04.121. Epub 2021 May 10.
Adult hearts have limited regenerative capacity. Hence, after acute myocardial infarction (MI), dead myocardial tissues are digested by immune cells and replaced by fibrosis, leading to ventricular remodeling and heart failure at the chronic stage. Direct reprogramming of the cardiac fibroblasts (CFs) into induced cardiomyocytes (iCMs) with cardiac transcription factors, including Gata4, Mef2c, and Tbx5 (GMT), may have significant potential for cardiac repair. Sendai virus (SeV) vectors expressing GMT have been reported to reprogram the mouse cardiac fibroblasts into iCMs without any risk of insertional mutagenesis. In vivo reprogramming improved the cardiac function after acute MI in immunodeficient mice. However, it is unknown whether the newly generated iCMs could exist in infarct hearts for a prolonged period and SeV-GMT can improve cardiac function after MI at the chronic stage in immunocompetent mice. Here, we show that SeV vectors efficiently infect CFs in vivo and reprogram them into iCMs, which existed for at least four weeks after MI, in fibroblast-linage tracing mice. Moreover, SeV-GMT improved cardiac function and reduced fibrosis and collagen I expression at 12 weeks after MI in immunocompetent mice. Thus, direct cardiac reprogramming with SeV vectors could be a promising therapy for MI.
成人心脏的再生能力有限。因此,急性心肌梗死 (MI) 后,死亡的心肌组织被免疫细胞消化,并被纤维化取代,导致慢性阶段心室重构和心力衰竭。心脏转录因子(包括 Gata4、Mef2c 和 Tbx5 (GMT))直接将心脏成纤维细胞 (CFs) 重编程为诱导性心肌细胞 (iCMs),可能具有显著的心脏修复潜力。表达 GMT 的仙台病毒 (SeV) 载体已被报道可将小鼠心脏成纤维细胞重编程为 iCMs,而不存在插入突变的风险。在免疫缺陷小鼠中,体内重编程可改善急性 MI 后的心脏功能。然而,尚不清楚新生成的 iCMs 是否能在梗死心脏中存在较长时间,以及 SeV-GMT 是否能改善免疫功能正常小鼠慢性阶段 MI 后的心脏功能。在这里,我们发现在纤维化谱系追踪小鼠中,SeV 载体可有效感染体内的 CFs 并将其重编程为 iCMs,这些 iCMs 在 MI 后至少存在四周。此外,SeV-GMT 可改善 MI 后 12 周免疫功能正常小鼠的心脏功能,并减少纤维化和胶原 I 的表达。因此,用 SeV 载体进行直接心脏重编程可能是一种有前途的 MI 治疗方法。